Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Bioresorbable vascular scaffolds (BVS), made either from polymers or from metals, are promising materials for treating coronary artery disease through the processes of percutaneous transluminal coronary angioplasty. Despite the opinion that bioresorbable polymers are more promising for coronary stents, their long-term advantages over metallic alloys have not yet been demonstrated. The development of new polymer-based BVS or optimization of the existing ones requires engineers to perform many very expensive mechanical tests to identify optimal structural geometry and material characteristics. mechanical testing opens the possibility for a fast and low-cost process of analysis of all the mechanical characteristics and also provides the possibility to compare two or more competing designs. In this study, we used a recently introduced material model of poly-l-lactic acid (PLLA) fully bioresorbable vascular scaffold and recently empowered numerical InSilc platform to perform mechanicals tests of two different stent designs with different material and geometrical characteristics. The result of inflation, radial compression, three-point bending, and two-plate crush tests shows that numerical procedures with true experimental constitutive relationships could provide reliable conclusions and a significant contribution to the optimization and design of bioresorbable polymer-based stents.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757700PMC
http://dx.doi.org/10.3389/fmedt.2021.724062DOI Listing

Publication Analysis

Top Keywords

bioresorbable vascular
12
fully bioresorbable
8
vascular scaffold
8
bioresorbable
5
application platform
4
platform development
4
development optimization
4
optimization fully
4
scaffold designs
4
designs bioresorbable
4

Similar Publications

Bioresorbable stents (BRS) have emerged as a groundbreaking development in the field of percutaneous coronary intervention (PCI) as they address the long-standing concerns of metallic stents. Nevertheless, the observed higher thrombosis rates in the first generation BRS, i.e.

View Article and Find Full Text PDF

Over the past few decades, researchers have attempted to overcome the disadvantages of metallic stents. This led to the birth of the first "Bioresorbable Scaffold" (BRS) model, the Absorb Bioresorbable Vascular Scaffold (BVS), in 1999 by Abbott. A stent that spontaneously resorbs shows a promising theoretical minimal risk of long-term stent thrombosis and omits the need for long-term antiplatelet therapy.

View Article and Find Full Text PDF

Restenosis is the main cause of failure after stent implantation during angioplasty. The localized, sustained delivery of an antirestenotic drug may reduce smooth muscle cell (SMCs) proliferation and thereby limit neointimal hyperplasia. The aim of this study was to develop degradable sirolimus-eluting polymer coatings that can be applied on bioresorbable polymer-based scaffolds via an ultrasonic coating system.

View Article and Find Full Text PDF

The Mo-14Re alloy, a promising candidate material for bioresorbable vascular scaffolds.

Acta Biomater

August 2025

National Key Laboratory of Automotive Chassis Integration and Bionics/School of Mechanical and Aerospace Engineering, Jilin University, Changchun, 130025, China; Institute of Structured and Architected Materials, Liaoning Academy of Materials, Shenyang 110167, China; Chongqing Research Institute of

Zinc‑, iron‑, and magnesium‑based biodegradable metals suffer inherent limitations as bioresorbable scaffold materials, including inappropriate degradation rates and insufficient mechanical strength. Pure molybdenum (Mo) has been proposed as an alternative, but its clinical application is hampered by brittleness and potential nephrotoxicity. A Mo alloy was engineered to address these challenges.

View Article and Find Full Text PDF

Polymer-based bioresorbable vascular scaffolds (BVS) have garnered significant attention in biomedical applications. Among various BVS, polycaprolactone (PCL)-based scaffolds exhibit excellent biocompatibility, flexibility, chemical stability, and controlled degradation. However, their low radial strength limits practical applicability.

View Article and Find Full Text PDF